Peptide inhibitors of the enzyme ACE-1 are also important for the development of new alternatives to Captopril® for control of hypertension, and significant research has been carried out recently concerning the development of ACE-1 inhibitory hydrolysates from dairy, microalgae, meat, seaweed, and cereal proteins [11,12,13,14,15,16]. Here, ACE is linked to hypertensive disorder.